Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toreforant in Moderate to Severe Plaque-type Psoriasis
NCT02295865Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2014
- Primary completion
- Mar 2016
- Countries
- 2
01
Overview
A Phase 2 trial of toreforant in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Nov 2014; status: completed.
02
Drugs
toreforant
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02295865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295865.